The Potential Role of T-Cell Memory Distribution as Predisposing Factor for Rejection in Heart Transplant Recipients

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2480-2484

  Lanio, N ^a   Sarmiento, E ^a   Gallego, A ^a   Fernandez Yanez J ^a   Palomo, J ^a   Perez Rojas J ^b   Carbone, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; COTRIMOXAZOLE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; FLUCONAZOLE; GANCICLOVIR; HEPATITIS B VACCINE; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PNEUMOCOCCUS VACCINE; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD45; CARDIOMYOPATHIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HEART VALVE DISEASES; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECEPTORS, CCR7;

EID: 68949206316     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.043     Document Type: Article

References (20)

1. Hall B.M. Cells mediating allograft rejection. Transplantation 51 (1991) 1141
2. Nozaki T., et al. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice. J lmmunol 181 (2008) 5257
3. Krieger N.R., Yin D.P., and Fathman C.G. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 184 (1996) 2013
4. Zhang Q., Chen Y., Fairchild R.L., et al. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J lmmunol 176 (2006) 770
5. Bingaman A.W., and Farber D.L. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 4 (2004) 846
6. Wang X.N., Proctor S.J., and Dickinson A.M. Frequency analysis of recipient-reactive helper and cytotoxic T lymphocyte precursors using a combined single limiting dilution assay. Transpl lmmunol 4 (1996) 247
7. Shiao S.L., Kirkiles-Smith N.C., Shepherd B.R., et al. Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol 179 (2007) 4397
8. Yamashita K., Choi U., Woltz P.C., et al. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells. Blood 103 (2004) 3986
9. Fukunaga A., Ishikawa T., Kishihata M., et al. Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool. Biol Blood Marrow Transplant 13 (2007) 1176
10. Oberbarnscheidt M.H., Ng Y.H., and Chalasan G. The roles of CD8 central and effector memory T-cell subsets in allograft rejection. Am J Transplant 8 (2008) 1809
11. Demirkiran A., Kok A., Kwekkeboom J., et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 12 (2006) 277
12. Meloni F., Vitulo P., Bianco A.M., et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77 (2004) 762
13. Salama A.D., Najafian N., Clarkson M.R., et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14 (2003) 1643
14. Bestard O., Cruzado J.M., Mestre M., et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 179 (2007) 4901
15. Vincenti F., Kirkman R., Light S., et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 338 (1998) 161
16. Kohm A.P., McMahon J.S., Podojil J.R., et al. Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176 (2006) 3301
17. Kreijveld E., Koenen H.J., Klasen I.S., et al. Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients. Am J Transplant 7 (2007) 249
18. Toso C., Edgar R., Pawlick R., et al. Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl Int 22 (2009) 182
19. Vlad G., Ho E.K., Vasilescu E.R., et al. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl Immunol 18 (2007) 13
20. Liu W., Putnam A.L., Xu-Yu Z., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203 (2006) 1701